New research suggests that higher global temperatures could have prompted an adaptation in Candida auris, allowing it to infect warm-blooded mammals.
Browsing: Disease Area > Fungal
Results from the Centers for Disease Control and Prevention has provided insights into why Candida auris outbreaks frequent in healthcare facilities.
The oral antifungal drug fluconazole, which is used to treat vaginal yeast infections, has been linked to higher rates of miscarriage if used during pregnancy, according to new research.
Researchers have discovered Candida albicans can cross the blood–brain barrier, triggering an immune response that results in the formation of granuloma-type structures and memory impairments.
Researchers have successfully used monoclonal antibodies to protect animal models from Candida infections for the first time, demonstrating their potential for treating this fungal disease.
Want to discover the best research that’s occurred this year? Editor, Martha Powell, highlights the best of 2018’s infectious diseases research in an A–Z.
We look at some of the highlights of our Twitter chat (#TalkFungi), where we questioned Ilan Schwartz, Andrej Spec, Rebecca Drummond and Jessie Uehling about all things mycology.
Join us for our Twitter chat with experts in the field on the 2 October at 15:00 BST/ 10:00 EDT, discussing fungal diseases, their burden and the challenges that face them #TalkFungi.
In this interview, take a look behind the scenes of a recent Future Microbiology paper on the emergence of antifungal resistance and what can be done in response with author, Justin Beardsley.